Onc.ai
Latest round
- Series A
Last raised
- Jan 2023
Total raised
- $31M
Investors
- 7
About Onc.ai
ai, Inc. focuses on leveraging AI to improve outcomes in oncology through deep learning models.31 mn.ai offers sophisticated AI-powered technology aimed at enhancing decision-making in cancer treatment, particularly through precision oncology. Its primary offerings utilize extensive real-world datasets, including diagnostic imaging and genomic data, to develop deep learning models that predict clinical outcomes in metastatic lung cancer.ai generates revenue through partnerships with healthcare providers and pharmaceutical companies, engaging in B2B transactions. The company’s offerings, which are in the investigational phase, provide insights that assist oncologists and pharmaceutical developers in making informed cancer treatment decisions.
Who invested in Onc.ai
7 investors across 2 rounds
See all investors in Onc.ai
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Onc.ai
Who invested in Onc.ai?
Onc.ai has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Onc.ai raised?
Onc.ai has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Onc.ai last raise money?
Onc.ai's most recent round on record is a Series A, in Jan 2023.
What does Onc.ai do?
Onc.ai is a healthcare company.
Where is Onc.ai headquartered?
Onc.ai is headquartered in San Carlos, US.
Which VCs invest in companies like Onc.ai?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Onc.ai's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Onc.ai? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.